Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/34863 |
Resumo: | Solange Cavalcante. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. The Global TB Programme, World Health Organization, Geneva, Switzerland. 2 Dept of Infection and Population Health, University College London, London, UK. 3 Public Health England, London, UK. 4 World Health Organization, Regional Office for Eastern Mediterranean, Egypt. 5 National TB Programme, Ministry of Health, Brasilia, Brazil. 6 Independent consultant, Switzerland. 7 Pedro Kourí Institute of Tropical Medicine, La Habana, Cuba. 8 Unit of Infectious Diseases, Dept of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, Sweden. 9 Dept of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia and Persahabatan Hospital, Jakarta, Indonesia. 10Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, Brazil. 11Hospital Nacionale Rosales, San Salvador, El Salvador. 12Center for TB Research, John Hopkins University, Baltimore, MD, USA. 13Tan Tock Seng Hospital, Singapore. 14TB Advocacy Consortium, Nairobi, Kenya. 15London School of Hygiene and Tropical Medicine, Blantyre, Malawi. 16World Health Organization, Regional Office for Europe, Denmark. 17Victorian Tuberculosis Program, Melbourne, Australia. 18KNCV Tuberculosis Foundation, Den Haag, The Netherlands. 19Dept of HIV and Global Hepatitis Programme, World Health Organization, Switzerland. 20Public Health Agency of Canada, Ottawa, ON, Canada. 21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, Italy. 22Dept of HIV/AIDS and TB Control Korea, Korea Centers for Disease Control and Prevention, Republic of Korea. 23Health Systems Research Unit, South African Medical Research Council, South Africa. 24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK. 25Dept of Epidemiology, Boston University School of Public Health, Boston, MA, USA. 26Main Medical Department, Ministry of Justice, Azerbaijan. 27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada. 28Centers for Disease Control and Prevention, USA. 29Dept of Public Health Sciences, Karolinska Institute, Solna, Sweden. 30Woolcock Institute of Medical Research University of Sydney and UNSW Australia, Sydney, Australia. 31WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy. 32Migration Health Department, International Organization of Migration, Geneva, Switzerland. 33Infectious Disease Division, Bureau for Global Health, US Agency for International Development, Washington, DC, USA. 34Zambart Project, Lusaka, Zambia. 35World Health Organization, Regional Office for the Western Pacific, Philippines. 36Pallas Health Research and Consultancy BV, Rotterdam, The Netherlands. 37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa. 38Knowledge, Ethics and Research Department, World Health Organization, Switzerland. 39European Centre for Disease Prevention and Control, Stockholm, Sweden. 40Dept of Clinical Epidemiology and Biostatistics and Dept of Medicine, GRADE Center, McMaster University, Hamilton, ON, Canada. 41Dept of Medicine, All India Institute of Medical Sciences, New Delhi, India. 42Sassari University, Sassari, Italy. 43Vanderbilt University School of Medicine, Nashville, TN, USA. 44National TB Programme, Ministry of Health, Riyadh, Saudi Arabia. 45European AIDS Treatment Group, Brussels, Belgium. 46Academic Medical Centre, University of Amsterdam, Dept of Global Health, Amsterdam, The Netherlands. 47HIV/TB and Penal System Projects, Russian Federation. 48Clinical Laboratories, Ministry of Health, Nicosia, Cyprus. 49Francis Crick Institute Mill Hill Laboratory, Dept of Medicine, Imperial College London, London, UK. 50Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo, Japan. 51Tuberculosis Competence Centre, Berne, Switzerland. |
id |
CRUZ_8fc214323da5f3ab6a236d1324eb59f1 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/34863 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Getahun, HaileyesusMatteelli, AlbertoAbubakar, IbrahimAziz, Mohamed AbdelBaddeley, AnnabelBarreira, DraurioBoon, Saskia denBorroto Gutierrez, Susana MartaBruchfeld, JudithBurhan, ErlinaCavalcante, SolangeCedillos, RolandoChaisson, RichardChee, Cynthia Bin-EngChesire, LucyCorbett, ElizabethDara, MasoudDenholm, JustinVries, Gerard deFalzon, DennisFord, NathanGale-Rowe, MargaretGilpin, ChrisGirardi, EnricoGo, Un-YeongGovindasamy, DarshiniGrant, Alison D.Grzemska, MalgorzataHarris, RossHorsburgh, C. RobertIsmayilov, AskerJaramillo, ErnestoKik, SandraKranzer, KatharinaLienhardt, ChristianLoBue, PhilipLönnroth, KnutMarks, GuyMenzies, DickMigliori, Giovanni BattistaMosca, DavideMukadi, Ya DiulMwinga, AlwynNelson, LisaNishikiori, NobuyukiOordt-Speets, AnoukRangaka, Molebogeng XheedhaReis, AndreasRotz, LisaSandgren, AndreasSañé Schepisi, MonicaSchünemann, Holger J.Sharma, Surender KumarSotgiu, GiovanniStagg, Helen R.Sterling, Timothy R.Tayeb, TamaraUplekar, MukundWerf, Marieke J. van derVandevelde, WimKessel, Femke vanHoog, Anna van'tVarma, Jay K.Vezhnina, NataliaVoniatis, ConstantiaNoordegraaf-Schouten, Marije VonkWeil, DianaWeyer, KarinWilkinson, Robert JohnYoshiyama, TakashiZellweger, Jean PierreRaviglione, Mario2019-08-19T12:33:26Z2019-08-19T12:33:26Z2015GETAHUN, Haileyesus et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal, v. 46, p. 1563-1576, 2015.0903-1936https://www.arca.fiocruz.br/handle/icict/3486310.1183/13993003.01245-20151399-3003Solange Cavalcante. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. The Global TB Programme, World Health Organization, Geneva, Switzerland. 2 Dept of Infection and Population Health, University College London, London, UK. 3 Public Health England, London, UK. 4 World Health Organization, Regional Office for Eastern Mediterranean, Egypt. 5 National TB Programme, Ministry of Health, Brasilia, Brazil. 6 Independent consultant, Switzerland. 7 Pedro Kourí Institute of Tropical Medicine, La Habana, Cuba. 8 Unit of Infectious Diseases, Dept of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, Sweden. 9 Dept of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia and Persahabatan Hospital, Jakarta, Indonesia. 10Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, Brazil. 11Hospital Nacionale Rosales, San Salvador, El Salvador. 12Center for TB Research, John Hopkins University, Baltimore, MD, USA. 13Tan Tock Seng Hospital, Singapore. 14TB Advocacy Consortium, Nairobi, Kenya. 15London School of Hygiene and Tropical Medicine, Blantyre, Malawi. 16World Health Organization, Regional Office for Europe, Denmark. 17Victorian Tuberculosis Program, Melbourne, Australia. 18KNCV Tuberculosis Foundation, Den Haag, The Netherlands. 19Dept of HIV and Global Hepatitis Programme, World Health Organization, Switzerland. 20Public Health Agency of Canada, Ottawa, ON, Canada. 21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, Italy. 22Dept of HIV/AIDS and TB Control Korea, Korea Centers for Disease Control and Prevention, Republic of Korea. 23Health Systems Research Unit, South African Medical Research Council, South Africa. 24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK. 25Dept of Epidemiology, Boston University School of Public Health, Boston, MA, USA. 26Main Medical Department, Ministry of Justice, Azerbaijan. 27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada. 28Centers for Disease Control and Prevention, USA. 29Dept of Public Health Sciences, Karolinska Institute, Solna, Sweden. 30Woolcock Institute of Medical Research University of Sydney and UNSW Australia, Sydney, Australia. 31WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy. 32Migration Health Department, International Organization of Migration, Geneva, Switzerland. 33Infectious Disease Division, Bureau for Global Health, US Agency for International Development, Washington, DC, USA. 34Zambart Project, Lusaka, Zambia. 35World Health Organization, Regional Office for the Western Pacific, Philippines. 36Pallas Health Research and Consultancy BV, Rotterdam, The Netherlands. 37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa. 38Knowledge, Ethics and Research Department, World Health Organization, Switzerland. 39European Centre for Disease Prevention and Control, Stockholm, Sweden. 40Dept of Clinical Epidemiology and Biostatistics and Dept of Medicine, GRADE Center, McMaster University, Hamilton, ON, Canada. 41Dept of Medicine, All India Institute of Medical Sciences, New Delhi, India. 42Sassari University, Sassari, Italy. 43Vanderbilt University School of Medicine, Nashville, TN, USA. 44National TB Programme, Ministry of Health, Riyadh, Saudi Arabia. 45European AIDS Treatment Group, Brussels, Belgium. 46Academic Medical Centre, University of Amsterdam, Dept of Global Health, Amsterdam, The Netherlands. 47HIV/TB and Penal System Projects, Russian Federation. 48Clinical Laboratories, Ministry of Health, Nicosia, Cyprus. 49Francis Crick Institute Mill Hill Laboratory, Dept of Medicine, Imperial College London, London, UK. 50Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo, Japan. 51Tuberculosis Competence Centre, Berne, Switzerland.2020-08-19Múltipla - Ver em Notas.Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to previously acquired Mycobacterium tuberculosis infection without clinical evidence of active tuberculosis (TB). Here we report evidence-based guidelines from the World Health Organization for a public health approach to the management of LTBI in high risk individuals in countries with high or middle upper income and TB incidence of <100 per 100 000 per year. The guidelines strongly recommend systematic testing and treatment of LTBI in people living with HIV, adult and child contacts of pulmonary TB cases, patients initiating anti-tumour necrosis factor treatment, patients receiving dialysis, patients preparing for organ or haematological transplantation, and patients with silicosis. In prisoners, healthcare workers, immigrants from high TB burden countries, homeless persons and illicit drug users, systematic testing and treatment of LTBI is conditionally recommended, according to TB epidemiology and resource availability. Either commercial interferon-gamma release assays or Mantoux tuberculin skin testing could be used to test for LTBI. Chest radiography should be performed before LTBI treatment to rule out active TB disease. Recommended treatment regimens for LTBI include: 6 or 9 month isoniazid; 12 week rifapentine plus isoniazid; 3-4 month isoniazid plus rifampicin; or 3-4 month rifampicin alone.engEuropean Respiratory SocietyManagement of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countriesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleMycobacterium tuberculosisLatent tuberculosis infectionWorld Health OrganizationGuidelinesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83104https://www.arca.fiocruz.br/bitstream/icict/34863/1/license.txt79178e5f2a0eb066867a274556814938MD51ORIGINALve_Haileyesus_Getahun_etal_INI_2015.pdfve_Haileyesus_Getahun_etal_INI_2015.pdfapplication/pdf380362https://www.arca.fiocruz.br/bitstream/icict/34863/2/ve_Haileyesus_Getahun_etal_INI_2015.pdfc96b2d048f1b0779017f6a729b3eaabcMD52TEXTve_Haileyesus_Getahun_etal_INI_2015.pdf.txtve_Haileyesus_Getahun_etal_INI_2015.pdf.txtExtracted texttext/plain67482https://www.arca.fiocruz.br/bitstream/icict/34863/3/ve_Haileyesus_Getahun_etal_INI_2015.pdf.txted063b6d02cf367784f1c2158245a078MD53icict/348632021-03-24 16:32:35.45oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-03-24T19:32:35Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries |
title |
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries |
spellingShingle |
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Getahun, Haileyesus Mycobacterium tuberculosis Latent tuberculosis infection World Health Organization Guidelines |
title_short |
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries |
title_full |
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries |
title_fullStr |
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries |
title_full_unstemmed |
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries |
title_sort |
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries |
author |
Getahun, Haileyesus |
author_facet |
Getahun, Haileyesus Matteelli, Alberto Abubakar, Ibrahim Aziz, Mohamed Abdel Baddeley, Annabel Barreira, Draurio Boon, Saskia den Borroto Gutierrez, Susana Marta Bruchfeld, Judith Burhan, Erlina Cavalcante, Solange Cedillos, Rolando Chaisson, Richard Chee, Cynthia Bin-Eng Chesire, Lucy Corbett, Elizabeth Dara, Masoud Denholm, Justin Vries, Gerard de Falzon, Dennis Ford, Nathan Gale-Rowe, Margaret Gilpin, Chris Girardi, Enrico Go, Un-Yeong Govindasamy, Darshini Grant, Alison D. Grzemska, Malgorzata Harris, Ross Horsburgh, C. Robert Ismayilov, Asker Jaramillo, Ernesto Kik, Sandra Kranzer, Katharina Lienhardt, Christian LoBue, Philip Lönnroth, Knut Marks, Guy Menzies, Dick Migliori, Giovanni Battista Mosca, Davide Mukadi, Ya Diul Mwinga, Alwyn Nelson, Lisa Nishikiori, Nobuyuki Oordt-Speets, Anouk Rangaka, Molebogeng Xheedha Reis, Andreas Rotz, Lisa Sandgren, Andreas Sañé Schepisi, Monica Schünemann, Holger J. Sharma, Surender Kumar Sotgiu, Giovanni Stagg, Helen R. Sterling, Timothy R. Tayeb, Tamara Uplekar, Mukund Werf, Marieke J. van der Vandevelde, Wim Kessel, Femke van Hoog, Anna van't Varma, Jay K. Vezhnina, Natalia Voniatis, Constantia Noordegraaf-Schouten, Marije Vonk Weil, Diana Weyer, Karin Wilkinson, Robert John Yoshiyama, Takashi Zellweger, Jean Pierre Raviglione, Mario |
author_role |
author |
author2 |
Matteelli, Alberto Abubakar, Ibrahim Aziz, Mohamed Abdel Baddeley, Annabel Barreira, Draurio Boon, Saskia den Borroto Gutierrez, Susana Marta Bruchfeld, Judith Burhan, Erlina Cavalcante, Solange Cedillos, Rolando Chaisson, Richard Chee, Cynthia Bin-Eng Chesire, Lucy Corbett, Elizabeth Dara, Masoud Denholm, Justin Vries, Gerard de Falzon, Dennis Ford, Nathan Gale-Rowe, Margaret Gilpin, Chris Girardi, Enrico Go, Un-Yeong Govindasamy, Darshini Grant, Alison D. Grzemska, Malgorzata Harris, Ross Horsburgh, C. Robert Ismayilov, Asker Jaramillo, Ernesto Kik, Sandra Kranzer, Katharina Lienhardt, Christian LoBue, Philip Lönnroth, Knut Marks, Guy Menzies, Dick Migliori, Giovanni Battista Mosca, Davide Mukadi, Ya Diul Mwinga, Alwyn Nelson, Lisa Nishikiori, Nobuyuki Oordt-Speets, Anouk Rangaka, Molebogeng Xheedha Reis, Andreas Rotz, Lisa Sandgren, Andreas Sañé Schepisi, Monica Schünemann, Holger J. Sharma, Surender Kumar Sotgiu, Giovanni Stagg, Helen R. Sterling, Timothy R. Tayeb, Tamara Uplekar, Mukund Werf, Marieke J. van der Vandevelde, Wim Kessel, Femke van Hoog, Anna van't Varma, Jay K. Vezhnina, Natalia Voniatis, Constantia Noordegraaf-Schouten, Marije Vonk Weil, Diana Weyer, Karin Wilkinson, Robert John Yoshiyama, Takashi Zellweger, Jean Pierre Raviglione, Mario |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Getahun, Haileyesus Matteelli, Alberto Abubakar, Ibrahim Aziz, Mohamed Abdel Baddeley, Annabel Barreira, Draurio Boon, Saskia den Borroto Gutierrez, Susana Marta Bruchfeld, Judith Burhan, Erlina Cavalcante, Solange Cedillos, Rolando Chaisson, Richard Chee, Cynthia Bin-Eng Chesire, Lucy Corbett, Elizabeth Dara, Masoud Denholm, Justin Vries, Gerard de Falzon, Dennis Ford, Nathan Gale-Rowe, Margaret Gilpin, Chris Girardi, Enrico Go, Un-Yeong Govindasamy, Darshini Grant, Alison D. Grzemska, Malgorzata Harris, Ross Horsburgh, C. Robert Ismayilov, Asker Jaramillo, Ernesto Kik, Sandra Kranzer, Katharina Lienhardt, Christian LoBue, Philip Lönnroth, Knut Marks, Guy Menzies, Dick Migliori, Giovanni Battista Mosca, Davide Mukadi, Ya Diul Mwinga, Alwyn Nelson, Lisa Nishikiori, Nobuyuki Oordt-Speets, Anouk Rangaka, Molebogeng Xheedha Reis, Andreas Rotz, Lisa Sandgren, Andreas Sañé Schepisi, Monica Schünemann, Holger J. Sharma, Surender Kumar Sotgiu, Giovanni Stagg, Helen R. Sterling, Timothy R. Tayeb, Tamara Uplekar, Mukund Werf, Marieke J. van der Vandevelde, Wim Kessel, Femke van Hoog, Anna van't Varma, Jay K. Vezhnina, Natalia Voniatis, Constantia Noordegraaf-Schouten, Marije Vonk Weil, Diana Weyer, Karin Wilkinson, Robert John Yoshiyama, Takashi Zellweger, Jean Pierre Raviglione, Mario |
dc.subject.en.pt_BR.fl_str_mv |
Mycobacterium tuberculosis Latent tuberculosis infection World Health Organization Guidelines |
topic |
Mycobacterium tuberculosis Latent tuberculosis infection World Health Organization Guidelines |
description |
Solange Cavalcante. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. The Global TB Programme, World Health Organization, Geneva, Switzerland. 2 Dept of Infection and Population Health, University College London, London, UK. 3 Public Health England, London, UK. 4 World Health Organization, Regional Office for Eastern Mediterranean, Egypt. 5 National TB Programme, Ministry of Health, Brasilia, Brazil. 6 Independent consultant, Switzerland. 7 Pedro Kourí Institute of Tropical Medicine, La Habana, Cuba. 8 Unit of Infectious Diseases, Dept of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, Sweden. 9 Dept of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia and Persahabatan Hospital, Jakarta, Indonesia. 10Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, Brazil. 11Hospital Nacionale Rosales, San Salvador, El Salvador. 12Center for TB Research, John Hopkins University, Baltimore, MD, USA. 13Tan Tock Seng Hospital, Singapore. 14TB Advocacy Consortium, Nairobi, Kenya. 15London School of Hygiene and Tropical Medicine, Blantyre, Malawi. 16World Health Organization, Regional Office for Europe, Denmark. 17Victorian Tuberculosis Program, Melbourne, Australia. 18KNCV Tuberculosis Foundation, Den Haag, The Netherlands. 19Dept of HIV and Global Hepatitis Programme, World Health Organization, Switzerland. 20Public Health Agency of Canada, Ottawa, ON, Canada. 21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, Italy. 22Dept of HIV/AIDS and TB Control Korea, Korea Centers for Disease Control and Prevention, Republic of Korea. 23Health Systems Research Unit, South African Medical Research Council, South Africa. 24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK. 25Dept of Epidemiology, Boston University School of Public Health, Boston, MA, USA. 26Main Medical Department, Ministry of Justice, Azerbaijan. 27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada. 28Centers for Disease Control and Prevention, USA. 29Dept of Public Health Sciences, Karolinska Institute, Solna, Sweden. 30Woolcock Institute of Medical Research University of Sydney and UNSW Australia, Sydney, Australia. 31WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy. 32Migration Health Department, International Organization of Migration, Geneva, Switzerland. 33Infectious Disease Division, Bureau for Global Health, US Agency for International Development, Washington, DC, USA. 34Zambart Project, Lusaka, Zambia. 35World Health Organization, Regional Office for the Western Pacific, Philippines. 36Pallas Health Research and Consultancy BV, Rotterdam, The Netherlands. 37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa. 38Knowledge, Ethics and Research Department, World Health Organization, Switzerland. 39European Centre for Disease Prevention and Control, Stockholm, Sweden. 40Dept of Clinical Epidemiology and Biostatistics and Dept of Medicine, GRADE Center, McMaster University, Hamilton, ON, Canada. 41Dept of Medicine, All India Institute of Medical Sciences, New Delhi, India. 42Sassari University, Sassari, Italy. 43Vanderbilt University School of Medicine, Nashville, TN, USA. 44National TB Programme, Ministry of Health, Riyadh, Saudi Arabia. 45European AIDS Treatment Group, Brussels, Belgium. 46Academic Medical Centre, University of Amsterdam, Dept of Global Health, Amsterdam, The Netherlands. 47HIV/TB and Penal System Projects, Russian Federation. 48Clinical Laboratories, Ministry of Health, Nicosia, Cyprus. 49Francis Crick Institute Mill Hill Laboratory, Dept of Medicine, Imperial College London, London, UK. 50Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo, Japan. 51Tuberculosis Competence Centre, Berne, Switzerland. |
publishDate |
2015 |
dc.date.issued.fl_str_mv |
2015 |
dc.date.accessioned.fl_str_mv |
2019-08-19T12:33:26Z |
dc.date.available.fl_str_mv |
2019-08-19T12:33:26Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
GETAHUN, Haileyesus et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal, v. 46, p. 1563-1576, 2015. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/34863 |
dc.identifier.issn.pt_BR.fl_str_mv |
0903-1936 |
dc.identifier.doi.none.fl_str_mv |
10.1183/13993003.01245-2015 |
dc.identifier.eissn.none.fl_str_mv |
1399-3003 |
identifier_str_mv |
GETAHUN, Haileyesus et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal, v. 46, p. 1563-1576, 2015. 0903-1936 10.1183/13993003.01245-2015 1399-3003 |
url |
https://www.arca.fiocruz.br/handle/icict/34863 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
European Respiratory Society |
publisher.none.fl_str_mv |
European Respiratory Society |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/34863/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/34863/2/ve_Haileyesus_Getahun_etal_INI_2015.pdf https://www.arca.fiocruz.br/bitstream/icict/34863/3/ve_Haileyesus_Getahun_etal_INI_2015.pdf.txt |
bitstream.checksum.fl_str_mv |
79178e5f2a0eb066867a274556814938 c96b2d048f1b0779017f6a729b3eaabc ed063b6d02cf367784f1c2158245a078 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813008852551991296 |